INTRODUCTION {#SEC1}
============

Microcins are a group of peptide antibiotics synthesized by enterobacteria ([@B1]). These compounds are produced under stress conditions and are effective against bacteria closely related to the producing strain. As a group, microcins are characterized by their small size (\<10 kDa) and synthesis by ribosomes. The mechanisms of toxicity and targets vary for different microcins. While some microcins depolarize the cell membrane ([@B2]), others act on intracellular targets. For instance, microcin B targets DNA gyrase ([@B3]), microcin J targets the DNA-dependent RNA polymerase ([@B4]), while microcin C targets aspartyl-tRNA synthetase ([@B5]). Microcins acting on intracellular targets are extensively post-translationally modified and have unusual chemical structures ([@B6]).

Typically, microcin gene clusters are located on plasmids and contain genes coding for microcin precursor peptide, self-immunity proteins and modification enzymes ([@B7]). Microcin C (McC), the smallest microcin known, is produced by *Escherichia coli* cells harboring a plasmid-borne gene cluster *mccABCDE* (Figure [1A](#F1){ref-type="fig"}). Mature McC (*M*w = 1178 Da) is a heptapeptide with covalently attached С-terminal adenosine monophosphate and a propylamine group attached to the phosphate (Figure [1B](#F1){ref-type="fig"}). McC enters susceptible *E. coli* cells through the YejABEF inner-membrane transporter ([@B8]). Inside the cell, the peptide part is processed by intracellular aminopeptidases ([@B9]) to release processed McC---a non-hydrolysable analog of aspartyl-adenylate, which specifically inhibits aspartyl-tRNA synthetase (Asp-RS), leading to cessation of translation ([@B5]).

![The *mcc* operon of *E. coli* and the biosynthesis of microcin C. (**A**) The *mccABCDE* operon is schematically presented at the top. Arrows indicate genes (drawn to scale). The position of the P*~mcc~* promoter is indicated. The sequence of the intergenic region between *mccA* and *mccB* is expanded below. The last codon of the *mccA* ORF and the first codon of the *mccB* ORF are highlighted. The putative intrinsic transcription terminator is indicated and self-complementary regions capable of forming the terminator hairpin are underlined. (**B**) The pathway of McC biosynthesis is shown. The heptapeptide shown on the left, the product of *mccA*, is adenylated by MccB ([@B10]) and the resulting peptide-adenylate is decorated with an aminopropyl moiety in the reaction that requires MccD and MccE ([@B11]), resulting in mature McC.](gku880fig1){#F1}

The product of *mccA*, the first gene of the McC biosynthesis operon, is a heptapeptide MRTGNAN that is converted into biologically active McC maturation intermediate in an adenylation reaction catalyzed by the MccB enzyme ([@B10]--[@B11]). Aminopropylation of the product of MccB-catalyzed reaction requires MccD and MccE and increases the biological activity ca. 10-fold ([@B11]). MccE is also responsible for detoxification of processed McC that accumulates in the producing cell ([@B12]). The *mccC* gene encodes a pump that exports produced McC and its maturation intermediate and also renders the producing cells resistant to external McC ([@B13]).

The transcription of the *mcc* operon initiates from a CAP (catabolite activator protein)-dependent promoter located upstream of the *mccA* gene when the producer enters stationary phase or is nutrient deprived ([@B14],[@B15]). Since both the *mccA* transcript, which codes for precursor peptide substrate, and the *mccB* transcript, which codes for the MccA peptide adenylation enzyme, are produced from the same promoter, there is likely a mechanism that regulates the substrate (MccA) to enzyme (MccB) ratio, so that a necessary level of McC production is achieved. In this work we uncover two mechanisms responsible for preferential synthesis of MccA compared to other products of the *mcc* operon. First, an intrinsic transcription terminator located between the *mccA* and *mccB* leads to the production of excess of monocistronic *mccA* transcripts. The function of this terminator requires ribosome binding to the *mccA* ORF. Second, ribosome binding leads to dramatic stabilization of the monocistronic *mccA* transcript. Together, these two effects lead to ca. 20-fold overproduction of *mccA* mRNA compared to *mccB* mRNA, so that a sufficiently high amount of substrate for McC synthesizing enzyme is achieved.

MATERIALS AND METHODS {#SEC2}
=====================

Bacterial strains and DNA {#SEC2-1}
-------------------------

*E. coli* strain BW25113 K-12 ([@B16]) was used if not indicated otherwise. *E. coli* BL21(DE3) was used as a sensitive strain for McC sensitivity tests. The pp70 plasmid is pBR322-based and bears a ∼6000 bp DNA fragment with the *mcc* gene cluster. To create pp70, a BstXI**-**АраLI fragment of plasmid pBM43 ([@B17]) was ligated in the EcoRI-AvaI fragment of the pBAD vector (Life Technologies). Both the vector and the insert were blunt ended before the ligation. The pp70 derivatives carrying *mccA* ATG^1^-\>TTA or Shine--Dalgarno ATAGGAGG→CCCTACTT (SD) mutations, as well as plasmid pp70Δ51 lacking nucleotides +59/+109 (the *mcc* transcription start is designated as +1) from the *mccA*--*mccB* intergenic region, were constructed by site-specific mutagenesis of pp70.

To create pFD_mcc_dir and pFD_mcc_inv plasmids, two pairs of oligonucleotides were annealed to yield two dsDNA fragments containing, in direct either inverted orientation, the *mcc* terminator hairpin along with 7 bp upstream and 13 bp downstream DNA flanked by AvaI (upstream) and EcoRV (downstream). The *mcc* part of resulting double-stranded DNA fragments corresponded to positions +71/+114 with respect to the *mcc* transcription start point. These fragments were ligated in the AvaI-EcoRV fragment of the pFD100 plasmid ([@B18]), between the lacUV5 promoter and the *galK* gene. To test *galK* gene expression, *E. coli* HB101 cells (ATCC33694) lacking functional *galK* gene were transformed with pFD-derivatives and streaked on McConkey indicator medium containing 1% galactose. The results were recorded after an overnight growth at 37°C.

RNA purification and differential RNA-seq {#SEC2-2}
-----------------------------------------

An aliquot of overnight culture was diluted hundred times with LB containing 100 μg/ml carbenicilline and grown for 4 h at 37°C until OD~600~ reached 2.0. Cells from 0.5 to 3 ml culture aliquots were collected by centrifugation, the supernatant was discarded, and cell pellets frozen in liquid nitrogen and stored at −70°C until further use. Cell pellets were resuspended in 30--50 μl of 20 mM Tris-HCl, pH 8.0, 1 mM EDTA, treated with 10 mg/ml lysozyme, mixed with 500 μl of TRIzol reagent (Invitrogen) and incubated for 5 min at room temperature. Hundred microliter of chloroform was added next and the samples were incubated for 15 min on ice until phase separation occurred. After 15-min centrifugation at 13,000×g the aqueous phase (∼300 μl) was transferred to a fresh tube. RNA was ethanol precipitated and then redissolved in 20--50 μl of DEPC-treated water. RNA concentration was determined using the NanoDrop spectrophotometer.

For whole transcriptome analysis by differential RNA-seq (dRNA-seq) ([@B19]) total RNA samples purified as described above were treated with DNase I (New England Biolabs) according to manufacturer\'s protocol to remove residual DNA from the samples. For depletion of processed transcripts, RNA was treated with Terminator™ 5′-phosphate-dependent exonuclease (TEX) (Epicentre) as previously described ([@B19]). cDNA libraries were constructed by *vertis* Biotechnology AG, Germany as described in ([@B19]). Sequencing of cDNA libraries was performed on an Illumina HiSeq2000 machine. In total, 1.8--2.4 million cDNA reads for each cDNA library were sequenced. The reads were mapped to the pp70 plasmid sequence. For data visualization, graphs representing the number of mapped reads per nucleotide were calculated and visualized using the Integrated Genome Browser (IGB) version 6.5.3 software from Affymetrix (<http://genoviz.sourceforge.net/>). The whole transcriptome dataset as well as further details of read mapping and sequencing statistics will be published elsewhere.

Northern blot hybridization {#SEC2-3}
---------------------------

The RNA samples were diluted to a final concentration of 0.25 μg/μl with formamide loading buffer (95% formamide, 0.025% xylencyanol, 0.025% bromphenol blue), and 1 μg of RNA was loaded on a 10% (19:1) denaturing polyacrylamide gel. After separation at 10W for 15--20 min, RNA was electroblotted to Hybond XL membrane (Amersham) using wet transfer system (BioRad). Transfer was performed for 1 h at 250 mA in 0.5xTBE. The membrane was air-dried and baked using 'optimal cross-link' settings of UV crosslinker (UVP). The membrane was blocked with 5 ml of ExpressHyb buffer (Clontech) for 30 min at 37°C, 20 pmoles of 5′ ^32^P-labeled oligonucleotide probe was added, and hybridization was allowed to proceed for 1 h (or overnight) at 37°C. The membrane was washed twice for 10 min with 2xSSC, 0.1% SDS and once for 10 min with 0.1xSSC, 0.1% SDS. Results were visualized using Storm Phosphorimager (GE Healthcare).

*In vivo* transcript stability measurements {#SEC2-4}
-------------------------------------------

Cells were grown as described above. After 4 h of growth, 100 μg/μl rifampicin was added and growth was continued. Five hundred microliter culture aliquots were taken before and 2, 5, 10 and 20 min after rifampicin addition. Samples were immediately mixed with 100 μl stop solution (95% ethanol, 5% phenol) and snap-frozen in liquid nitrogen. After thawing on ice, samples were centrifuged for 5 min at 5000xg and RNA was purified as described above.

Estimation of *in vivo* termination efficiency {#SEC2-5}
----------------------------------------------
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Primer extension reactions {#SEC2-6}
--------------------------

1--6 μg RNA was reverse-transcribed using MuMLV reverse transcriptase (Invitrogen) according to manufacturer\'s instructions. Briefly, primers were annealed to RNA for 10 min at 65°C followed by transfer on ice. MuMLV reverse transcriptase was added to make up a total volume of 10 μl and a final MuMLV concentration of 10 u/μl in 1x reaction buffer (50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl~2~, 10 mM DTT); reactions were allowed to proceed at 37°C for 55 min. Reactions were terminated by the addition of an equal volume of formamide loading buffer and loaded on 8% denaturing polyacrylamide gel.

5′-RACE {#SEC2-7}
-------

Twenty microgram of total RNA was treated with DNAse I (New England Biolabs) according to manufacturer\'s instructions. To half of the sample (10 μg) five units of TAP (Tobacco Acid Pyrophosphatase, Epicentre) (+TAP reaction) was added. An equal amount of water was added instead of enzyme to another half, making control-TAP reaction. Reactions were incubated for 1 h at 37°C in 25 μl reaction volume in the presence of 20 units of RNaseOUT (Invitrogen). RNA was next phenol/chloroform extracted and ethanol precipitated. The pellet was resuspended in 50 μl ligation buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl~2~, 1 mM DTT) with 120 units of T4 RNA ligase I (New England Biolabs) and 50 pmoles of RNA primer (5′ GGUAUUGCGGUACCCUUGUACGC 3′), and ligation was performed overnight at 16°C. Following phenol/chloroform extraction and ethanol precipitation, the RNA/primer pellet was resuspended in 10 μl of water, heated at 65°C for 10 min and immediately transferred on ice. The cDNA synthesis was carried out with 100 units of Super Script III from the First-Strand Synthesis System for RT-PCR (Invitrogen) according to manufacturer\'s instructions for 50 min at 55°C using a primer complementary to the beginning of *mccB* gene. Two microliter aliquots of cDNA synthesis reactions were used as templates for PCR (one primer was identical to RNA primer, another was complementary to the beginning of the *mccB* gene). PCR products were resolved on 2% agarose gels. Amplified fragments of expected length were excised from the gel and cloned into the pT7Blue cloning vector from the pT7Blue Perfectly Blunt Cloning Kit (Novagen). Inserts in several recombinant plasmids were sequenced using standard T7-promoter oligonucleotide primer. The 5′ ends of transcripts were determined by the position of the junction site between the sequence corresponding to the RNA primer and *mcc* sequences.

3′-RACE {#SEC2-8}
-------

Ten microgram of total RNA was mixed with 40 pmol of 5′ pre-adenylated DNA-adapter (New England Biolabs) and 200 units of truncated T4 RNA ligase 2 (New England Biolabs) in 50 mM Tris-HCl, pH 7.5, 10 mM MgCl~2~, 1 mM DTT, 10% PEG. Reactions proceeded at 25°C for 1 h and were terminated by incubation at 60°C for 25 min. Five microliter of reaction mixtures was used as templates for cDNA strand synthesis with 100 units SuperScript III reverse-transcriptase (Invitrogen) according to the manufacturer\'s protocol using 1 pmole of primer complementary to the DNA adapter. Two microliter of reverse-transcription reactions was used as a template for PCR amplification (one primer was complementary to the DNA adapter, another to the template strand of the *mccA* gene). The product of PCR amplification was cloned directly to the pGEM-T easy vector (Promega) using pGEM-T easy PCR ligation kit (Promega) according to the manufacturer\'s protocol. Plasmids from insert-positive clones were purified and insert sequences were determined.

*In vitro* transcription {#SEC2-9}
------------------------

Promoter complexes were allowed to form for 10 min at 37°C in 10 μl reactions containing 40 mM Tris-HCl, pH 8.0, 40 mM KCl, 10 mM MgCl~2~, 100 nM *E. coli* RNA polymerase σ^70^ holoenzyme (Epicentre) and 10 nM DNA templates. Reactions were supplemented with 10 μM CpApUpC, 25 μM ATP and GTP, and 0.33 μM α-^32^P-CTP (3000 Ci/mmol) and stalled elongation complexes were allowed to form for 5 min 37°C and reactions were diluted 10-fold with a chase mix that resulted in the final concentrations of 500 mM KCl, 2.5 μM of ATP and GTP, and 10 μM of UTP and CTP. Reactions were incubated for 15 min at 25°C and terminated by the addition of formamide loading buffer.

For chase reactions coupled with *in vitro* translation, stalled elongation complexes were formed as described above except that 50 mM NaCl was used instead of KCl. Stalled elongation complexes were diluted 10-fold with *in vitro* translation mix (*In Vitro* Protein Synthesis, ΔRibosome, or Δ(aa, tRNA) PURExpress kit, New England Biolabs) and reactions were allowed to proceed for 15 min at 25°C. Reaction volume was made up to 100 μl with ASE buffer (0.3 M NaAc, 0.5% SDS, 5 mM EDTA, pH5.3) and reactions were extracted twice with acid phenol/chloroform, precipitated with ethanol and dissolved in formamide loading buffer.

For single-round *in vitro* transcription promoter complexes were allowed to form for 10 min at 37°C in 10 μl reactions containing 40 mM Tris-HCl, pH 8.0, 40 mM KCl, 10 mM MgCl~2~, 100 nM *E. coli* RNA polymerase σ^70^ holoenzyme (Epicentre) and 10 nM DNA templates. Reactions were supplemented with 50 μg/ml heparin, 100 μM ATP, 100 μM GTP, 100 μM UTP, 10 μM CTP and 0.33 μM α-^32^P-CTP (3000 Ci/mmol). Reactions were incubated for 15 min at 37°C to allow single-round RNA synthesis and terminated by addition of 10 μl formamide loading buffer.

Isolation of ribosomal fractions {#SEC2-10}
--------------------------------

Cells were resuspended in 25 mM Tris, pH 8.0, 60 mM KCl, 10 mM MgCl~2~, 20% sucrose and lysed by five cycles of freezing in liquid nitrogen---thawing at 37°C. The suspension was next diluted 4-fold by the same buffer and supplemented with 0.5% Brij58, 10 u/ml DNAse I, 0.15% deoxycholic acid and 3 mM MgSO~4~. The suspension was incubated on ice for 30 min and cell debris was pelleted by 30-min centrifugation at 30,000xg. The lysate was loaded onto a 10--40% sucrose gradient (in 25 mM Tris, pH 7.8, 50 mM KCl, 10 mM MgCl~2~, 3 mM DTT) and centrifuged for 16 h at 18,000 rpm in SW38Ti rotor. Fractions were collected by dripping from percolated bottom of centrifuge tube.

Toeprinting {#SEC2-11}
-----------

The *mcc* RNA (+1/+146 with respect to the natural transcription start site) was transcribed *in vitro* using T7 High Yield RNA Synthesis Kit (New England Biolabs) and an appropriate DNA template generated by PCR, and purified with RNA Clean&Concentrator 25 kit (ZymoResearch).

One pmol of purified *in vitro* transcribed *mcc* RNA was mixed, in a total volume of 5 μl, with 2 pmoles of ^32^P-labeled primer complementary to the 3′-end of RNA and *in vitro* translation mix (*In Vitro* Protein Synthesis, ΔRibosome or Δ(aa, tRNA) PURExpress kit, New England Biolabs) components. When added, thiostrepton was used at a final concentration of 50 μM and was preincubated with *in vitro* translation mix components for 3 min at 37°C. Ribosomes were allowed to bind for 15 min at 37°C and then reverse transcription was performed using Superscript III reverse transcriptase (Invitrogen) according to manufacturer\'s instructions. Reactions were extracted twice with acid phenol/chloroform, precipitated with ethanol, dissolved in formamide loading buffer and loaded on 5% denaturing polyacrylamide gel along with sequencing reactions prepared using Thermo Sequenase Cycle Sequencing Kit (Affymetrix).

Probing of RNA structure {#SEC2-12}
------------------------

*In vitro* synthesized *mcc* RNA (above) was dephosphorylated by calf intestinal phosphatase (Fermentas) and then 5′-end labeled with T4-polynucleotide kinase (Fermentas) according to manufacturer\'s protocols. 0.2 pmol of 5′-^32^P-labeled RNA was denatured for 5 min at 95°C in 10 μl of prefold buffer (40 mM HEPES pH 8.0, 100 mM NH~4~Cl, 4 mM DTT) and chilled on ice for 5 min. MgCl~2~ was added to final concentration 10 mM and RNA was allowed to fold by incubating the reactions for 10 min at 37°C followed by the addition of 1 μg of yeast RNA. Reactions were next supplied with 1 μl of RNase T1 (0.01 u/μl) or RNase T2 (0.01 u/μl) (Boehringer-Mannheim) and incubated for 5 min at 37°C. When probing the RNA structure in the presence of ribosomes, the *in vitro* translation mix (*In Vitro* Protein Synthesis PURExpress kit components, preincubated with thiostrepton) was added after RNA denaturation in prefold buffer.

RNase T1 marker ladders were obtained by incubating 0.2 pmol 5′-^32^P- labeled RNA in 1xSequencing buffer (20 mM sodium citrate pH 5, 1 mM EDTA, 7 M urea) for 5 min at 95°C. Reactions were chilled and 1.5 μl of RNase T1 (0.1 U/μl) was added followed by 5 min incubation at 37°C. All reactions were stopped by the addition of equal volume (10 μl) of formamide loading buffer, except for reactions contained PURExpress system, which were stopped by the addition of 100 μl ASE buffer (0.3 M NaAc, 0.5% SDS, 5 mM EDTA, pH 5.3), extracted twice with acid phenol/chloroform, precipitated with ethanol and then dissolved in formamide loading buffer.

Plate assay for McC production {#SEC2-13}
------------------------------

Hundred microliter of fresh night culture of *E. coli* BL21 (DE3) cells was mixed with 5 ml 0.7% (soft) LB agar and poured over a 1.5% LB agar plate. After drying, 5 μl aliquots of tested cell cultures or McC solutions of known concentrations (1--20 μM) were applied on the plate surface. Plates were incubated at 37°C for 3 h to allow the lawn to grow, and the sizes of growth inhibition zones formed around antibiotic solution drops were measured.

RESULTS {#SEC3}
=======

An abundant short *mccA* transcript is required for McC production {#SEC3-1}
------------------------------------------------------------------

To get an overview of the *mccABCDE* operon transcription, total RNA was prepared from *E. coli* cells harboring the McC-production plasmid. Cells were grown in LB broth to late exponential phase, a condition, when the culture was actively synthesizing McC (([@B14]) and data not shown). Total RNA was purified from a culture aliquot and subjected to the differential RNA-seq (dRNA-seq) procedure that allows one to identify the 5′ ends of transcripts ([@B19]). During dRNA-seq, half of the RNA sample is subjected to TAP treatment prior to library construction, while another half is treated with 5′-phosphate-dependent exonuclease (TEX), an enzyme that destroys RNA molecules containing 5′-monophosphates, followed by TAP treatment and library construction. Sequencing reads present in libraries prepared from TEX treated RNA (+TEX) are enriched with sequences whose 5′ ends correspond to transcription initiation start points, while the TAP-only (−TEX) treated samples contain reads corresponding to both transcription initiation start points and exo- and endonucleolytic processing/degradation events. The results of dRNA-seq analysis for RNAs synthesized from the *mcc* operon are shown in Figure [2A](#F2){ref-type="fig"}. As can be seen, at conditions of McC production high coverage corresponding to the beginning of the *mcc* operon was observed in the −TEX library. Coverage was decreased ca. 30-fold in samples treated with TEX. The location of 5′ ends of these reads corresponds to the published location of the start point of P*~mcc~*, a CAP-cAMP-dependent promoter located upstream of *mccABCDE* ([@B14],[@B15]). Inspection of Figure [2A](#F2){ref-type="fig"} also reveals the apparent absence of other strong transcription initiation points within the *mccABCDE* operon, indicating that transcription from P*~mcc~* is primarily responsible for operon expression at conditions tested. Several potential minor start points within the *mccB* and *mccE* gene are apparent. These start points are not preceded by recognizable promoter consensus elements and their significance is unknown. The mRNAs initiated from these hypothetical start points do not contain full-sized *mccB* ORF and so can have no influence on the MccA/MccB ratio in the producing cell, which is the subject of this study.

![*In vivo* analysis of the *mcc* operon transcripts. (**A**) Analysis of the *mccABCDE* operon of *E. coli* using differential RNA-Seq. RNA was extracted from *E. coli* cells harboring the McC-production plasmid pp70 and grown to late exponential phase in LB medium. Half of RNA was treated with Terminator™ 5′-phosphate-dependent exonuclease (TEX) (+TEX), while another half was left untreated (−TEX) and then converted into a cDNA library, which was subjected to high-throughput Illumina sequencing. cDNA sequencing reads were aligned to the *mcc* operon and visualized as coverage plots representing the number of reads per nucleotide ('k' for thousands of reads) in the IGB (Affymetrix). In the IGB screenshot shown plasmid coordinates are indicated in the middle; gray arrow represent annotated ORFs, black arrow denotes P*~mcc~* and the ORF of the small peptide *mccA* is shown as a red arrow. (**B**) At the left-hand side, results of detection of *mcc* transcripts in cells harboring the wild-type McC-production plasmid pp70 and its derivative pp70Δ51 harboring a deletion in the *mccA--mccB* region are shown: top---Northern blotting with an *mccA*-specific probe. Positions of Decade™ RNA Markers are indicated on the right. Middle---primer extension using a primer annealing at the beginning of the *mccB* gene. Bottom---primer extension using a primer annealing to plasmid-borne *bla* gene. At the right-hand side, the levels of McC production by cells harboring the wild-type or mutant McC-production plasmids and used for transcript analysis are shown. (**C**) Summary of *mccA* transcript mapping. A fragment of the *mccABCDE* operon DNA (in black) and the short *mccA* transcript (in blue) are schematically shown, arrows in the end of *mccA* transcript indicate results of 3′ end mapping by 3′-RACE. SD sequences of *mccA* and *mccB* ORFs are shown in green.](gku880fig2){#F2}

Northern-blotting analysis using an oligonucleotide complementary to the *mccA* ORF was also performed. A prominent ∼100 nt long RNA was present in McC-producing cells (Figure [2B](#F2){ref-type="fig"}, left, top panel, lane 1) but not in control cells lacking the *mcc* plasmid (data not shown). This RNA was also not detected in cells harboring an *mcc* plasmid with a deletion that removed the putative terminator in the intergenic region between the *mccA* and *mccB* genes (Figure [2B](#F2){ref-type="fig"}, left, top panel, lane 2). The amount of control transcript from plasmid-borne *bla* gene was unaltered by the deletion (Figure [2B](#F2){ref-type="fig"}, left, bottom panel, compare lanes 1 and 2).

The 5′ and 3′ ends of the *mccA* RNA were identified using RACE. A single 5′ end located 29 nt upstream of the *mccA* ATG codon was detected, coinciding with the previously reported P*~mcc~* start point ([@B15]) and dRNA-seq data (above). The 3′ ends of the *mccA* transcripts mapped to three consecutive adenine residues downstream of the stem-loop formed by the putative intergenic transcription terminator hairpin. Thus, the size of the short *mccA* transcript is ∼105--107 nt. It contains the entire *mccA* ORF as well as a 52--54-nt 3′ untranslated region.

To monitor the polycistronic (*mccA* and downstream genes) *mcc* transcript, primer extension reactions with a primer annealing in the *mccB* gene were performed. A single primer extension product was observed (Figure [2B](#F2){ref-type="fig"}, left, middle panel, lane 1) and its 5′ end matched the transcription start point of the monocistronic *mccA* transcript (data not shown). The amount of polycistronic transcript appears to be unchanged in cells harboring a plasmid with deletion of the putative terminator (Figure [2B](#F2){ref-type="fig"} left, middle panel, compare lanes 1 and 2).

Semi-quantitative analysis using *in vitro* transcribed mono- and polycistronic *mcc* RNA as markers allowed us to estimate that there are ca. 20 molecules of monocistronic transcript for every polycistronic *mcc* transcript molecule present in McC-producing cells (data not shown). Cells harboring an *mcc* plasmid with disrupted putative terminator produced ca. 30 times less McC than cells harboring the wild-type plasmid (Figure [2B](#F2){ref-type="fig"}, right). The result thus suggests that the short *mccA* transcript is required for high McC production, presumably by allowing the synthesis of sufficient amounts of the MccA peptide to be converted into McC by MccB. The results of *mccA* transcript mapping are summarized in Figure [2C](#F2){ref-type="fig"}.

Short *mccA* transcript is highly stable and is ribosome-bound {#SEC3-2}
--------------------------------------------------------------

The data presented above can be explained by either transcription termination or transcript processing between the *mccA* and the *mccB* ORFs. A processing event would be expected to generate a new 5′ end that should be detectable by primer extension with oligonucleotides annealing to *mccB*. No such primer extension product was detected (data not shown), suggesting that transcription termination is likely responsible for the appearance of the short *mccA* transcript. The high ratio of monocistronic to polycistronic *mccA* transcripts may result from very efficient transcription termination in the intergenic region or it may be caused by differential transcript stability (a combination of these two effects is also possible). To determine transcript stabilities, McC-producing cells were treated with rifampicin, an inhibitor of transcription initiation, and decay of *mcc* RNA abundance was followed over time by Northern blotting (for *mccA* transcript) and primer extension (for polycistronic transcript). The results are presented in Figure [3A](#F3){ref-type="fig"}. As can be seen, the half-life of polycistronic transcript was several minutes, i.e. comparable to half-lives of most *E. coli* mRNAs ([@B20]). In contrast, the short *mccA* transcript was exceedingly stable (almost no change in transcript abundance after a 20-min incubation with rifampicin). The exceptional stability of the *mccA* transcript may be responsible for the abnormally low (∼3%) ratio of TEX-resistant transcripts revealed by dRNA-seq (Figure [2A](#F2){ref-type="fig"}), since transcripts that persist for a long time could lose their 5′ triphosphate moiety ([@B21]).

![The *mccA* transcript is stable and ribosome-bound. (**A**) An McC-producing culture of *E. coli* harboring the pp70 plasmid was treated with rifampicin. At times indicated, aliquots of the culture were withdrawn, total RNA was purified and amounts of *mccA* and *mccB* transcripts were measured by Northern blotting and primer extension, respectively, as described in Figure [2B](#F2){ref-type="fig"} legend. The results were quantified and the mean values and standard deviations in mRNA abundance obtained in three independent experiments are presented. (**B**) Lysates of McC-producing cells were subjected to sucrose gradient centrifugation, fractions were collected and the amounts of *mccA* RNA were determined by Northern blotting. Gradient profile of sucrose centrifugation is shown below the gel. (**C**) Total RNA was purified from McC-producing *E. coli* culture harboring the pp70 plasmid or from equally grown cultures harboring pp70 derivatives with a mutated *mccA* gene initiating codon (ATG^1^-\>TAA) or multiple substitutions in the SD sequence of *mccA* and amounts of the *mccA* transcript (top), *mccB* transcript (middle) or *bla* transcript (bottom) were determined by Northern blot (*mccA*) or primer extension (*mccB*, *bla*) using appropriate primers.](gku880fig3){#F3}

We next wondered what could be the reason of exceptional stability of the *mccA* transcript, an obviously important part of the mechanism that contributes to preferential accumulation of the *mccA* message in the cell. The short transcript could be intrinsically stable (for example, there are known cases of 3′ end stem-loops stabilizing bacterial RNA ([@B22]--[@B25])) or it could be stabilized by ribosome binding to and/or translation of the *mccA* ORF ([@B26]) (since the *mccA* ORF is only seven codons long, only one ribosome can bind to *mccA* RNA). Using sucrose gradient centrifugation, we showed that the *mccA* transcript is only present in the ribosome-containing fraction and is undetectable in the free RNA fraction (Figure [3B](#F3){ref-type="fig"}), consistent with idea that ribosome-binding and/or translation may have a stabilizing effect on short *mccA* mRNA. We next generated mutant variants of McC-producing plasmid that contained (i) a TAA instead of the initiating ATG codon of the *mccA* gene or (ii) down-mutations in the Shine-Dalgarno (SD) sequence of the *mccA* gene. As expected, cells harboring mutant plasmids did not produce McC (data not shown). Primer extension analysis using the *mccB*-specific primer indicated that compared to the wild-type, mutation in the initiating codon had no effect on transcript abundance, while mutation of the SD sequence decreased the abundance of this transcript ca. 3-fold (Figure [3C](#F3){ref-type="fig"}). The latter effect appears to have been caused by increased mRNA degradation, since introduction of substitutions in the *mccA* SD sequence led to the appearance of multiple additional primer extension products shorter than the primary product extending to the *mcc* transcript start point (data not shown). In contrast, Northern blot analysis indicated that the initiating codon mutation decreased, while SD mutation abolished the production of the short transcript. In the case of initiating codon mutant, the residual short transcript was found to be ribosome-bound and was stable (data not shown).

*In vitro* analysis of transcription termination in the *mccA--mccB* intergenic region {#SEC3-3}
--------------------------------------------------------------------------------------

While our inability to detect the *mccA* transcript in cells where ribosome binding to *mccA* was disrupted made it impossible to determine stabilities of mutant transcripts, the result hinted that the free short transcript is unstable or, more interestingly, that ribosome binding may somehow stimulate short transcript production. To address this issue, *in vitro* transcription and transcription-translation experiments were performed. Since *mcc* promoter has very low basal transcription activity *in vitro* (data not shown), we used a chimeric transcription template containing a strong T7 A1 promoter with modified initial transcribed sequence (extending from positions −67 to +30, 5′-tccagatcccgaaaatttatcaaaaagagt[attgact]{.ul}taaagtctaacctatag[gatact]{.ul}tacagccAtcgagagggccacggcgaacagcaaccca-3′, the promoter consensus elements are underlined, the +1 position is capitalized) fused to a fragment of *mcc* DNA from position +1 to +154 with respect to the *mcc* promoter transcription start point. Transcription templates containing mutations at the *mccA* initiating codon and/or its SD sequence (above) were also created. Transcription templates were combined with *E. coli* RNA polymerase σ^70^ holoenzyme and transcription was initiated with a C^−1^pA^+1^pU^+2^pC^+3^ primer, ATP, GTP and radioactive CTP. Since the first adenine in the template strand is located in position +35 of the template, transcription is stalled before this position. The stalled transcription complexes contain a radioactive nascent 34-nt long RNA whose extension can be monitored upon the addition of UTP. As can be seen from Figure [4A](#F4){ref-type="fig"}, lane 2, very little, if any, transcription termination was detected with the wild-type template. However, when elongation of the nascent 34-mer RNA was performed in the presence of defined PURExpress *in vitro* translation system, a new transcript whose 3′ end matched the 3′ end of *mccA* RNA observed *in vivo* was produced on the wild-type template (Figure [4A](#F4){ref-type="fig"}, lane 5). The PURExpress system used in Figure [4A](#F4){ref-type="fig"}, lane 5, contains all components of the translation machinery and ribosomes. To determine whether transcription termination in the *mccA--mccB* intergenic region requires translation of the *mccA* gene, *in vitro* transcription of wild-type template was performed in the presence of PURExpress (Δaa, tRNA) system lacking amino acids and tRNA (Figure [4A](#F4){ref-type="fig"}, lane 4), or in the presence of PURExpress ΔRibosome system that lacks ribosomes but contains all other translation system components (Figure [4A](#F4){ref-type="fig"}, lane 3). As can be seen, transcription termination required the presence of ribosomes but was not dependent on the presence of amino acids and tRNA.

![Ribosomes stimulate transcription termination in the *mccA--mccB* intergenic region *in vitro*. (**A**) Stalled *E. coli* RNA polymerase transcription elongation complexes containing a 34-nt long radioactively labeled RNA were formed on a DNA template containing the T7 A1 promoter fused to a fragment of *mcc* operon extending from position +1 to position +154. Transcription elongation was allowed to resume by the addition of NTPs (lane 1), or NTPs with PURExpress ΔRibosome (lane 2), Δ(aa, tRNA) (lane 3) or full system (lane 4). An autoradiograph of a denaturing gel showing reaction product separation is shown. (**B**) *In vitro* transcribed *mccA* RNA was combined with PURExpress ΔRibosome (lane 2), Δ(aa, tRNA) (lane 3) or full system (lanes 4 and 5) at conditions identical to those used in panel A experiment, and toeprinting was performed. In lane 5, reaction contained 50 μM thiostrepton. The products of toeprinting reactions were resolved by denaturing gel-electrophoresis and revealed by autoradiography. The 3′ end of the cDNA products synthesized in the toeprint experiment and labeled +17/20 correspond to bound ribosomes with the first (+17) or second (+20) codons of *mccA* located in the ribosomal P site ([@B27]). (**C**) Transcription complexes were formed as described in A on wild-type or mutant transcription templates with mutated first codon of the *mccA* gene (ATG^1^-\>TAA) or substitutions in the *mccA* SD sequence and transcription elongation was allowed to proceed. (**D**) *In vitro* transcribed wild-type *mccA* RNA or RNAs harboring *mccA* (ATG^1^-\>TAA) or SD sequence substitutions were subjected to toeprinting reaction in the presence or in the absence of PURExpress Δ(aa, tRNA) system. All designations are as in panel B.](gku880fig4){#F4}

Our data suggest that the presence of ribosomes, even in the absence of translation, stimulates transcription termination in the *mccA--mccB* intergenic region. To detect ribosome binding to the *mccA* transcript, a toeprinting experiment was conducted using purified monocistronic *mccA* mRNA prepared by *in vitro* transcription with T7 RNAP from an appropriate DNA template. In the absence of ribosomes reverse transcriptase stalled at several points along the transcript (Figure [4B](#F4){ref-type="fig"}, lane 1). The stalling apparently increased in the presence of PURExpress ΔRibosome system compared to what was observed with just pure RNA (Figure [4B](#F4){ref-type="fig"}, compare lanes 2 and 1). In the presence of PURExpress (Δaa, tRNA) system, a prominent toeprint was observed (Figure [4B](#F4){ref-type="fig"}, lane 3). The major toeprints were located 17/20 nt downstream of the *mccA* ORF start point, corresponding to the ribosome location at the first and second codons of *mccA* ([@B27]). Additional minor toeprints were located further downstream (up to position +31) and correspond to ribosome binding within the *mccA* ORF. A toeprinting experiment with PURExpress full system was also conducted (Figure [4B](#F4){ref-type="fig"}, lane 4). At these conditions, which support the synthesis of the MccA heptapeptide, a change in the toeprinting pattern was observed. In addition to toeprints corresponding to ribosome bound at the beginning and within the *mccA* ORF, another toeprint, at position +36, which corresponds to ribosome stalled at the last sense codon of *mccA*, was detected. The addition of thiostrepton, an antibiotic that inhibits ribosome translocation ([@B28]), to reactions containing full system led to accumulation of the toeprint at position +17 corresponding to ribosome bound at the initiating codon and eliminated the downstream toeprints (Figure [4B](#F4){ref-type="fig"}, lane 5).

Since the PURExpress (Δaa, tRNA) system causes efficient transcription termination (Figure [4A](#F4){ref-type="fig"}, lane 3) and appearance of a toeprint (Figure [4B](#F4){ref-type="fig"}, lane 3), we infer that ribosome binding to the *mccA* ORF in the absence of translation stimulates downstream transcription termination. The fact that efficient transcription termination is observed in the presence of the full system and thiostrepton (Supplementary Figure S1) is also consistent with this inference. Further support to the idea that ribosome binding is sufficient to induce transcription termination came from *in vitro* transcription termination analysis using mutant *mccA* templates. As can be seen (Figure [4C](#F4){ref-type="fig"}, compare lanes 4 and 5) transcription termination in the presence of PURExpress full system was unaffected by a mutation in the initiating codon of *mccA* but was strongly reduced by the SD sequence mutations (Figure [4C](#F4){ref-type="fig"}, lane 6). In the latter case, a diffuse band migrating just above a sharp band corresponding to the transcription termination event was observed. This band is caused by nucleolytic degradation of the full-sized transcript since it is also observed when phenol-extracted full-sized *in vitro* transcribed RNA is combined with transcription/translation reactions components (Supplementary Figure S2).

A toeprinting experiment with purified *mccA* mRNAs containing mutations in the initiating codon of *mccA* or in the SD sequence was next conducted in the presence of PURExpress (Δaa, tRNA) system (Figure [4D](#F4){ref-type="fig"}). A toeprint at positions corresponding to ribosome binding at the first and second *mccA* codons was seen with the wild-type template (Figure [4D](#F4){ref-type="fig"}, lane 2) while no toeprint was detected with mRNA containing substitutions in the SD sequence (Figure [4D](#F4){ref-type="fig"}, lane 6). The substitution of the initiating codon decreased the intensity of toeprint corresponding to ribosome bound at the initiating codon of *mccA* but led to a strong toeprint at position +31 (Figure [4D](#F4){ref-type="fig"}, lane 4), corresponding to ribosome bound at internal AUG codon located in the +1 reading frame within the *mccA* ORF.

We infer from these data that a ribosome bound upstream of or within *mccA* stimulates the formation of transcription terminator responsible for formation of the short *mccA* transcript that is required for McC synthesis. It therefore follows that the part of *mccA* RNA that is covered by the bound ribosome participates in interactions that inhibit the formation of the transcription terminator hairpin. Two types of experiments support this view. First, when transcription elongation was performed in the presence of an oligonucleotide annealing to *mccA* transcript positions +69/+91 (oligo 1) and thus covering the left arm of the putative stem-loop structure of the terminator (Figure [5D](#F5){ref-type="fig"}), transcription termination was low even in the presence of PURExpress system (Figure [5A](#F5){ref-type="fig"}, compare lanes 2 and 3). This result is consistent with an idea that for transcription termination to occur, a stem-loop structure at the terminator must form. On the other hand, when the transcription reaction was performed in the presence of DNA oligonucleotide annealing to *mccA* transcript positions +26/+48 (oligo 2) and thus overlapping with position of the bound ribosome, strong transcription termination was observed even in the absence of PURExpress system (Figure [5B](#F5){ref-type="fig"}, lane 1). Thus, oligo 2 mimicked ribosome binding, presumably by relieving inhibitory interactions in the nascent *mccA* RNA that suppressed termination. A DNA oligonucleotide annealing to *mcc* region +51 to +71 (oligo 3), immediately downstream of the bound ribosome also induced transcription termination (Figure [5B](#F5){ref-type="fig"}, lane 2), though the effect was weaker than with oligo 2. Thus, both the part of the *mccA* RNA that is covered by the ribosome and the segment located immediately downstream inhibit transcription termination.

![Mapping an element of the *mccA* transcript that suppresses transcription termination in the *mccA--mccB* intergenic region. (**A**) Stalled *E. coli* RNA polymerase transcription elongation complexes containing a 34-nt long radioactively labeled RNA were formed on a DNA template containing the T7 A1 promoter fused to a fragment of *mcc* operon extending from position +1 to position +154. Transcription elongation was allowed to resume by the addition of NTPs (lane 1), NTPs with PURExpress ΔRibosome (lane 2) or NTPs with PURExpress ΔRibosome in the presence of oligonucleotide oligo 1 (lane 3, see also panel D). An autoradiograph of a denaturing gel showing reaction product separation is shown. (**B**) Stalled *E. coli* RNA polymerase transcription elongation complexes containing a 34-nt long radioactively labeled RNA were formed on a DNA template containing the T7 A1 promoter fused to a fragment of *mcc* operon extending from position +1 to position +154. Elongation was resumed by the addition of NTPs in the presence or in the absence of DNA oligonucleotides oligo 2 or oligo3. (**C**) Single-round *in vitro* transcription reactions were performed on a DNA containing the T7 A1 promoter fused to a fragment of *mcc* operon extending from position +1 to position +154 (lane 1) and derivative templates that contained deletions extending from position +1 to a position, indicated in the template name (i.e. template labeled +15 lacked nucleotides +1/+14). The sites of termination are indicated by arrows. (**D**) The monocistronic *mccA* transcript. The SD sequence is shown in green, the *mccA* ORF in red. The area covered by a ribosome bound to the SD sequence, annealed oligos 1, 2 and 3, and the termination hairpin positions are indicated.](gku880fig5){#F5}

To better map the upstream boundary of the *mccA* RNA segment that affects the terminator formation, *in vitro* transcription reactions with a series of T7 A1-*mcc* templates containing deletions in the *mcc* part were performed in the absence of ribosomes (Figure [5C](#F5){ref-type="fig"}). As can be seen, removal of up to 29 nt of the initial transcribed *mcc* sequence had no effect on transcription termination. Removal of 44 nt caused weak termination, while removal of first 59 or 73 nt strongly stimulated transcription termination in the absence of ribosomes. Overall, the results of this analysis demonstrate that *mccA* RNA positions +30 to +60 inhibit the terminator function in nascent *mccA* RNA.

We next wished to probe the structure of the *mccA* RNA and determine whether this structure could be affected by ribosome binding. Both wild-type *mccA* RNA and mutant versions with substitutions in the initiating codon and the SD sequence were probed with RNases T1 and T2, which are specific to unpaired Gs (T1) and all unpaired nucleotides (T2). RNA digested with RNase T1 under denaturing conditions was used as a size marker. The results, presented in Figure [6A](#F6){ref-type="fig"}, are consistent with a structure presented in Figure [6B](#F6){ref-type="fig"}, showing the existence of two prominent stem-loop structural elements. The first element is located immediately downstream of bound ribosome, and contains an RNase T2 hypersensitive loop (loop 1), which is resistant to RNase T1 because it contains only A and U residues. Another stem-loop structure corresponds to the transcription terminator hairpin. Its loop, loop 2, is sensitive to both RNase T2 and RNase T1 (the sensitivity to the latter enzyme is due to the presence of G~88~). The two mutant RNA structures appear to be the same as that of the wild-type *mccA* RNA.

![Structural and functional probing of *mccA* transcript. (**A**) ^32^P-5′-end labeled *in vitro* synthesized wild-type or mutant *mccA* RNA was digested with RNase T1 or RNase T2. Reaction products were resolved by denaturing PAGE and revealed by autoradiography. Lanes labeled 'control' show material that was not treated with RNAses. Lanes labeled 'SEQ T1' are marker lanes, showing digestion pattern obtained with RNase T1 under denaturing conditions (cleavages at every G). In lanes labeled 'RNase T1' and 'RNase T2' transcripts were re-folded in the presence of 10 mM MgCl~2~ and then digested with RNases. In lanes labeled 'PURExpress' wild-type *mccA* RNA was folded in the presence of PURExpress full system in the presence of thiostrepton. (**B**) A secondary structure of *mccA* RNA produced by RNAfold software (<http://rna.tbi.univie.ac.at/>) and consistent with RNase probing results. Cleavage positions by RNase T1 and RNase T2 are shown, respectively, with black and white asterisks. Elements of the structure (loops, L, and hairpins, H) are also marked on the gel shown in panel A. A fragment of *mccA* tested for *in vivo* termination activity is indicated. (**C**) A DNA fragment coding for a hairpin structure and adjacent sequences shown in panel C was cloned in direct (pFD_mcc_dir) and inverted (pFD_mcc_inv) orientations between the *galK* reporter and the *lac*UV5 promoter of plasmid pFD100. The resulting plasmids, as well as control pFD51 plasmid lacking the promoter, were transformed into *galK*^−^*E. coli* cells and transformants were then tested for GalK activity on McConkey indicator agar plates. Overnight growth of cells is shown.](gku880fig6){#F6}

We next performed the probing experiment in the presence of PURExpress full system. While ribosomes seem to have generally protected *mccA* RNA from RNase T2 digestion, the hypersensitivity in both loops persisted (Figure [6A](#F6){ref-type="fig"}, compare lanes 7 and 8, and lanes 10 and 11). The result either suggests that changes caused by bound ribosome are not sensed by the probing method used (for example, they may involve a tertiary, rather than secondary structure change) or, that such changes only occur in the context of shorter nascent RNAs, which fold co-transcriptionally.

Since results presented above failed to demonstrate a conformational change in *mccA* transcript caused by ribosome binding, we wished to prove that *mccA* terminator alone, in the absence of interfering upstream *mccA* sequences, can cause transcription termination *in vivo*. Accordingly, we cloned a fragment of *mcc* DNA from position +71 to +114 with respect to the transcription start point in between the *lac*UV5 promoter and the *galK* gene of plasmid pFD100 ([@B18]). This fragment contains the *mccA* terminator hairpin, the A/T-rich downstream region and a fragment of the upstream *mcc* hairpin revealed by footprinting experiments (Figure [6B](#F6){ref-type="fig"}). Plasmids containing *mcc* inserts in both orientations were constructed. *E. coli galK^−^* cells transformed with pFD100 plasmid formed purple-colored streaks on McConkey agar plates (Figure [6C](#F6){ref-type="fig"}) due to transcription from the *lac*UV5 promoter. Control cells transformed with pFD51 plasmid lacking this promoter formed white-color streaks. Cells transformed with a plasmid containing the *mcc* insert in 'direct' orientation also formed white-color streaks, demonstrating that the cloned segment of *mcc* DNA efficiently prevented *galK* transcription from upstream promoter. In contrast, cells transformed with a plasmid containing the *mcc* insert in 'inverted' orientation formed purple-color streaks. We infer from this experiment that a fragment of *mcc* DNA carrying the inverted repeat from the *mccA--mccB* intergenic region and 7 upstream and 13 downstream base pairs functions as a unidirectional transcription terminator *in vivo*.

The ribosome-dependent mechanism of *mccA* RNA production is evolutionarily conserved {#SEC3-4}
-------------------------------------------------------------------------------------

The *mcc*-like operons appear to be widespread in phylogenetically diverse bacteria ([@B6]). While no production of McC-like compounds by these operons has been shown yet, some of these compounds were recently validated by enzymatic synthesis of *in vitro* using cognate pairs of MccB-like enzymes/predicted MccA-like substrates ([@B29]). It is reasonable to expect that the main features controlling the synthesis of these compounds should be conserved. Indeed, for all *mcc*-like operons identified to date, a long intergenic region separating the *mccA* and *mccB* homologs and containing terminator-like sequences can be identified ([@B6]). In *Helicobacter pylori* strain G27 ([@B30]), the *mcc*-like operon is encoded on a 10,032-bp plasmid pHPG27 (NC_011334) and contains three genes, *mccA*, *mccB* and *mccC* (Figure [7A](#F7){ref-type="fig"}). The intergenic region between pHPG27 *mccA* and *mccB* is 84 bp long (the corresponding region in *E. coli mcc* is 74 bp long, Figure [7A](#F7){ref-type="fig"}). To determine whether a short *H. pylori mccA* transcript is produced and, if so, whether its production can be stimulated by ribosome binding, an *in vitro* transcription experiment was performed using as a template a DNA fragment containing the T7 A1 promoter fused to the initial transcribed region of *H. pylori mcc* operon and in the presence of PURExpress system. In the absence of ribosomes, *E. coli* RNAP produced a single full-sized transcript, which extended into *mccB* (Figure [7B](#F7){ref-type="fig"}, lane 1). In contrast, in the presence of ribosomes an additional radioactive band was observed (Figure [7B](#F7){ref-type="fig"}, lanes 2 and 3). Electrophoretic mobility of this band was consistent with a transcription product whose 3′ end is located shortly after the hairpin of predicted terminator. Since production of the terminated product was observed both in the presence and in the absence of amino acids and tRNA (Figure [7B](#F7){ref-type="fig"}, compare lanes 2 and 3), the result indicates that similarly to the situation observed in *E. coli*, ribosome binding causes transcription termination in the *mccA--mccB* intergenic region of *H. pylori*.

![*H. pylori mcc* operon analysis. (**A**) Schematic representations of *E. coli* and *H. pylori mcc* operons (drawn not to scale). All designations are as in Figure [1C](#F1){ref-type="fig"}. The *mccA--mccB* intergenic region of *H. pylori* is expanded below with the stop codon of *mccA*, the start codon of *mccB* and the location of inverted repeat that may form a transcription terminator indicated. (**B**) Stalled *E. coli* RNA polymerase transcription elongation complexes containing a 32-nt long radioactively labeled RNA were formed on a DNA template containing the T7 A1 promoter fused to a fragment of *H. pylori mcc* operon extending from position +1 to position +137. Transcription elongation was allowed to resume by the addition of NTPs in the presence of PURExpress ΔRibosome (lane 1), Δ(aa, tRNA) (lane 2) or full (lane 3) translation systems. An autoradiograph of a denaturing gel showing reaction product separation is shown.](gku880fig7){#F7}

DISCUSSION {#SEC4}
==========

In this work, we studied transcriptional control mechanisms that ensure high levels of production of peptide--nucleotide antibiotic microcin C. The transcription of the entire *mcc* operon occurs from a single upstream promoter. The activity of this promoter requires CAP-cAMP and thus McC production only occurs during nutrient deprivation ([@B14],[@B15]). Once transcription of *mcc* genes is initiated, a proper ratio of the MccA peptide, a product of promoter-proximal gene and a substrate of promoter distal biosynthetic genes products MccB, MccD and MccE, needs to be maintained to assure continuous and high levels of McC production. We here show that the intergenic region between the *mccA* and *mccB* genes plays an important role in controlling the overall level McC synthesis. A deletion in this region dramatically reduces McC production while leaving all the coding sequences of *mcc* genes intact. The deletion also abolishes the production of a highly abundant 105--107-nt transcript that contains the *mccA* ORF. Consequently, most of the MccA propeptide is synthesized from this short *mccA* RNA and the observed high abundance of this transcript evidently contributes to efficient McC production.

The monocistronic *mccA* RNA is produced at transcription terminator located in the intergenic region between *mccA* and *mccB*. However, the function of this terminator remains masked by secondary or tertiary interactions within the *mccA* RNA, such that in the absence of ribosome binding/*mccA* translation the RNA polymerase proceeds to transcribe downstream *mcc* genes. If a ribosome binds to the SD sequence upstream of the *mccA*, transcription termination becomes possible. While the ribosome binding is essential for transcription termination in the *mccA--mccB* intergenic region, translation of the *mccA* ORF is not. This effect appears to be due to both the very efficient interaction of ribosome with the *mccA* SD sequence and the presence of additional sites, including internal out-of-frame ATG codons within *mccA* where a ribosome can reside causing transcription termination. Presumably, a ribosome bound upstream of or within *mccA* causes a change in the nascent transcript structure that allows transcription terminator structure to form, although experiments with *in vitro* transcribed *mccA* RNA failed to reveal a structural change at least at the level of RNA secondary structure. The mechanism of short *mccA* transcript generation through ribosome-induced transcription termination may be a conserved feature of predicted *mcc*-like operons in diverse bacteria. This possibility is clearly implied by our *in vitro* analysis of transcription of *H. pylori mcc* operon. The result is particularly striking since sequence conservation between the *mccA* genes and untranslated regions of *E. coli* and *H. pylori* is lacking.

High (∼40% and more) termination efficiencies at the *mccA--mccB* intergenic terminator can be obtained *in vitro* in the presence of ribosomes. The large ratio in monocistronic and polycistronic *mcc* transcripts abundance observed *in vivo* suggests similarly high termination efficiencies *in vivo*. The steady-state ratio of monocistronic to polycistronic transcripts (ca. 20:1) is determined by their respective synthesis and degradation rates. Since both transcripts are synthesized from the same promoter, the ratio of their synthesis rates is determined by the termination efficiency. At steady state, the transcript synthesis has to be matched by the transcript decay; from this, it is straightforward to obtain a relationship that connects the termination efficiency with the ratio of the transcript concentrations, and the ratio of their half-lives (see Materials and Methods for derivation). The half-life of the polycistronic transcript can be estimated at ∼3 min, while the monocistronic transcript is stable on the timescale of the cell division, so that its half-life is determined by the cell doubling time (∼30 min). From the above it can then be estimated that the *in vivo* termination efficiency should be around 65%.

It is clear that exceptional stability of *mccA* mRNA is responsible for the large ratio of monocistronic to polycistronic transcripts observed. This stability is also due to ribosome binding, so that a ribosome bound to *mccA* ORF dramatically stabilizes the transcript. Since in the absence of translation the *mccA* transcript decays rapidly, it is very tempting to speculate that once bound to the *mccA* message, a ribosome does not dissociate from it anymore, shifting back to the beginning of the seven-codon message once translation of the MccA heptapeptide is completed. Such mechanism would provide an additional boost in the amount of MccA substrate synthesized and made available for adenylation by the MccB. Experiments aimed at testing this scenario are currently in progress in our laboratory.
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